---
$id: https://graph.org.ai/products/commodity/51184015
$type: Product
source: UNSPSC
code: "51184015"
title: "Tolazamide"
class: "51184000"
classTitle: "Antidiabetic and hyperglycemic sulfonylureas"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tolazamide

**UNSPSC Code**: 51184015
**Class**: [Antidiabetic and hyperglycemic sulfonylureas](Antidiabetic and hyperglycemic sulfonylureas.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-diabetic agent with the molecular formula C14H21N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 9LT1BRO48Q, chemically known as 4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide but more generally known as tolazamide, which bears US NIH Compound Identifier 5503. European Medicines Agency schedules Tolazamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11147MIG. The term TOLAZAMIDE is an International Non-Proprietary Name WHO schedules tolazamide in its Anatomical Therapeutic Chemical (ATC) Classification. TOLAZAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule tolazamide under HS 29350090 and SITC 51580. As of Q4 2014, TOLAZAMIDE remains US FDA's Preferred Term for this commodity. Tolazamide bears US NLM identifiers UMLS ID C0040372 and NCI Concept Code C29502. SMILES: S(=O)(=O)(NC(=O)NN1CCCCCC1)C1CCC(CC1)C.

